SCHEDULE OF COMMON STOCK PURCHASE WARRANTS ISSUED AND OUTSTANDING (Details) - $ / shares |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2022 |
Dec. 31, 2021 |
|
| Equity [Abstract] | ||
| Warrants Outstanding, Beginning balance | 29,700,000 | 40,764,666 |
| Weighted Average Exercise Price, Beginning balance | $ 0.13 | $ 0.13 |
| Warrants outstanding, granted | 500,000 | 9,400,000 |
| Weighted average exercise price, granted | $ 0.10 | $ 0.09 |
| Warrants outstanding, expired | (4,480,000) | (20,464,666) |
| Weighted average exercise price, expired | $ 0.11 | $ 0.11 |
| Warrants Outstanding, Beginning balance | 25,720,000 | 29,700,000 |
| Weighted Average Exercise Price, Beginning balance | $ 0.13 | $ 0.13 |
| X | ||||||||||
- Definition Weighted average exercise price, expired. No definition available.
|
| X | ||||||||||
- Definition Warrants weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, granted. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|